GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Computer-Aided Detection (CADe) in Routine Colonoscopy: Gastroenterology | July 2026
11

Computer-Aided Detection (CADe) in Routine Colonoscopy: Gastroenterology | July 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated July 1, 2026

Introduction:

Adenoma detection rate (ADR) is the most important quality indicator for colonoscopy and is directly associated with reduced colorectal cancer risk. Although randomized trials have shown that artificial intelligence–based computer-aided detection (CADe) improves ADR, its effectiveness in routine clinical practice has remained uncertain. This large real-world quality improvement study evaluated the impact of CADe implementation across the Veterans Health Administration.

Why was this study needed?

  • Randomized trials have shown improved ADR with CADe, but real-world evidence has been inconsistent.
  • The effectiveness of CADe across different endoscopist experience levels remained unclear.
  • Quality improvement data are needed before widespread implementation.
  • Increasing ADR is a proven strategy for colorectal cancer prevention.
  • AI-assisted colonoscopy is rapidly entering routine clinical practice.

Results:

  • Implementation of CADe significantly increased adenoma detection rates, with a 22% higher likelihood of detecting at least one adenoma compared with standard colonoscopy.
  • The benefit was consistent across all endoscopists, including those who already had high baseline adenoma detection rates.
  • CADe did not increase unnecessary biopsies, prolong withdrawal time, or alter colorectal cancer detection, supporting its efficient integration into routine practice.

Clinical Impact:

This large real-world study confirms that AI-assisted colonoscopy improves adenoma detection outside clinical trials and benefits both average and high-performing endoscopists. These findings support broader implementation of CADe as a quality improvement tool to enhance colorectal cancer prevention.

Bottom Line:

Computer-aided detection (CADe) improves adenoma detection in everyday clinical practice regardless of baseline endoscopist performance. AI is becoming an effective quality-enhancement tool that complements, rather than replaces, the expertise of the endoscopist.

Related Q&A

12

Cold vs Hot Snare Polypectomy for Pedunculated Colorectal Polyps: Endoscopy | July 2026

A randomized controlled trial published in Endoscopy (July 2026) compared cold snare polypectomy (CSP) with hot snare polypectomy (HSP) for small pedunculated colorectal polyps. Key findings CSP eliminated...

13

Novel Catheter Improves Endoscopic Transpapillary Gallbladder Drainage in Malignant Biliary Stricture VideoGIE | July 2026

Introduction: Acute cholecystitis in patients with malignant biliary obstruction can be difficult to manage, particularly when surgery is not feasible. Endoscopic transpapillary gallbladder drainage (ETGBD) is an attractive...

14

AI for Early Esophageal Cancer Detection: AJG | July 2026

Introduction: Early detection of esophageal squamous cell carcinoma (ESCC) is critical for curative endoscopic treatment. However, subtle lesions are often missed during routine endoscopy. This meta-analysis evaluated whether...

15

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal...

16

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains...

17

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer